weight loss amgen news - Search News

Amgen says obesity drug caused up to 20% weight loss

Barron's on MSN · 4d

Amgen Stock Dives After Weight-Loss Drug Data. Here’s What to Know.

Amgen stock was dropping in premarket trading after releasing data from a Phase 2 study for its experimental weight-loss drug, MariTide. The pharmaceutical company said in a statement that after 52 weeks,

CNBC on MSN · 4d

Amgen says obesity drug caused up to 20% weight loss after a year, with no plateau

The results shed light on how MariTide may measure up to weight loss injections from Novo Nordisk and Eli Lilly and other experimental treatments.

Newsweek on MSN · 2d

Amgen Obesity Drug More Effective Than Competitors

A new weight loss drug called MariTide caused 20 percent weight loss in a recent trial, even better than Wegovy or Ozempic.

3d

What's Next for Amgen Obesity Drug After Investors Disappointed by Results

Shares in Amgen fell on Tuesday after they announced the results of a trial for their weight loss drug MariTide.

9hon MSN

Down 12.3% at One Point in a Single Trading Session, Is Amgen Stock Still a Buy?

The market didn't appreciate Amgen 's ( AMGN 1.00%) latest clinical data update, with the biopharma's shares falling more ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results